BMS-582949

DRUG3 trials

Sponsors

Bristol-Myers Squibb

Conditions

PsoriasisRheumatoid Arthritis, NOSVascular Diseases

Phase 2

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis

CompletedNCT00399906

Bristol-Myers SquibbPsoriasis

Start: 2007-08-31End: 2009-04-30Updated: 2015-12-07

Efficacy Study of p38 Kinase Inhibitor to Treat Patients With Atherosclerosis

CompletedNCT00570752

Bristol-Myers SquibbVascular Diseases

Start: 2008-12-31End: 2010-12-31Updated: 2015-12-07

PoC in Rheumatoid Arthritis With Methotrexate

CompletedNCT00605735

Bristol-Myers SquibbRheumatoid Arthritis, NOS

Start: 2008-03-31End: 2009-09-30Updated: 2015-10-12